Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 88 articles:
HTML format
Text format



Single Articles


    February 2018
  1. JIANG Z, Chen T, Chen J, Ying S, et al
    Hand-spinning chrysotile exposure and risk of malignant mesothelioma: A case-control study in Southeastern China.
    Int J Cancer. 2018;142:514-523.
    PubMed     Text format     Abstract available


    January 2018
  2. SETTE G, Salvati V, Giordani I, Pillozzi E, et al
    Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells.
    Int J Cancer. 2018 Jan 17. doi: 10.1002/ijc.31260.
    PubMed     Text format     Abstract available


  3. INOUE-CHOI M, Hartge P, Liao LM, Caporaso N, et al
    Association between long-term low-intensity cigarette smoking and incidence of smoking-related cancer in the national institutes of health-AARP cohort.
    Int J Cancer. 2018;142:271-280.
    PubMed     Text format     Abstract available


  4. XU X, Huang Z, Zheng L, Fan Y, et al
    The efficacy and safety of anti-PD-1/PD-L1 antibodies combined with chemotherapy or CTLA4 antibody as a first-line treatment for advanced lung cancer.
    Int J Cancer. 2018 Jan 10. doi: 10.1002/ijc.31252.
    PubMed     Text format     Abstract available


  5. MORRIS S, Vachani A, Pass HI, Rom WN, et al
    Whole Blood FPR1 mRNA Expression Predicts Both Non-Small Cell and Small Cell Lung Cancer.
    Int J Cancer. 2018 Jan 5. doi: 10.1002/ijc.31245.
    PubMed     Text format     Abstract available


  6. YANG TY, Teng CJ, Lin TC, Chen KC, et al
    Transcriptional repression of Aurora-A gene by wild-type p53 through directly binding to its promoter with histone deacetylase 1 and mSin3a.
    Int J Cancer. 2018;142:92-108.
    PubMed     Text format     Abstract available


    December 2017
  7. DAI L, Smith CD, Foroozesh M, Miele L, et al
    The sphingosine kinase 2 inhibitor ABC294640 displays anti-non-small cell lung cancer activities in vitro and in vivo.
    Int J Cancer. 2017 Dec 26. doi: 10.1002/ijc.31234.
    PubMed     Text format     Abstract available


  8. WU Y, Shi H, Jiang M, Qiu M, et al
    The clinical value of combination of immune checkpoint inhibitors in cancer patients: A meta-analysis of efficacy and safety.
    Int J Cancer. 2017;141:2562-2570.
    PubMed     Text format     Abstract available


  9. THEOFYLAKTOPOULOU D, Midttun O, Ueland PM, Meyer K, et al
    Impaired functional vitamin B6 status is associated with increased risk of lung cancer.
    Int J Cancer. 2017 Dec 14. doi: 10.1002/ijc.31215.
    PubMed     Text format     Abstract available


  10. ZHENG Y, Deng Z, Yin J, Wang S, et al
    The association of genetic variations in DNA repair pathways with severe toxicities in NSCLC patients undergoing platinum-based chemotherapy.
    Int J Cancer. 2017;141:2336-2347.
    PubMed     Text format     Abstract available


  11. DETTERBECK FC
    Letter to the Editor: Re: The Impact of Overdiagnosis on the Selection of Efficient Lung Cancer Screening Strategies.
    Int J Cancer. 2017 Dec 1. doi: 10.1002/ijc.31185.
    PubMed     Text format    


    November 2017
  12. WANG Y, Wu W, Zhu M, Wang C, et al
    Integrating expression related SNPs into genome-wide gene-pathway-based analysis identified novel lung cancer susceptibility genes.
    Int J Cancer. 2017 Nov 30. doi: 10.1002/ijc.31182.
    PubMed     Text format     Abstract available


  13. ZHAO S, Gao F, Zhang Y, Zhang Z, et al
    Bevacizumab in Combination with Different Platinum-based Doublets in the First-line Treatment for Advanced Nonsquamous Non-small-cell Lung Cancer: A Network Meta-Analysis.
    Int J Cancer. 2017 Nov 24. doi: 10.1002/ijc.31175.
    PubMed     Text format     Abstract available


  14. LI Y, Ye Z, Chen S, Pan Z, et al
    ARHGEF19 interacts with BRAF to activate MAPK signaling during the tumorigenesis of non-small cell lung cancer.
    Int J Cancer. 2017 Nov 22. doi: 10.1002/ijc.31169.
    PubMed     Text format     Abstract available


  15. SATTERFIELD L, Shuck R, Kurenbekova L, Allen-Rhoades W, et al
    miR-130b directly targets ARHGAP1 to drive activation of a metastatic CDC42-PAK1-AP1 positive feedback loop in Ewing sarcoma.
    Int J Cancer. 2017;141:2062-2075.
    PubMed     Text format     Abstract available


  16. KIM J, Field A, Schultz KAP, Hill DA, et al
    The prevalence of DICER1 pathogenic variation in population databases.
    Int J Cancer. 2017;141:2030-2036.
    PubMed     Text format     Abstract available


  17. UNVER N, Delgado O, Zeleke K, Cumpian A, et al
    Reduced IL-6 levels and tumor-associated phospho-STAT3 are associated with reduced tumor development in a mouse model of lung cancer chemoprevention with myo-inositol.
    Int J Cancer. 2017 Nov 14. doi: 10.1002/ijc.31152.
    PubMed     Text format     Abstract available


  18. ZHANG R, Jia M, Xu Y, Qian D, et al
    ERCC4 regulatory variant predict Grade-3 or -4 toxicities in patients with advanced non-small cell lung cancer treated by platinum-based therapy.
    Int J Cancer. 2017 Nov 14. doi: 10.1002/ijc.31153.
    PubMed     Text format     Abstract available


  19. DIETZ S, Harms A, Endris V, Eichhorn F, et al
    Spatial distribution of EGFR and KRAS mutation frequencies correlates with histological growth patterns of lung adenocarcinomas.
    Int J Cancer. 2017;141:1841-1848.
    PubMed     Text format     Abstract available


    October 2017
  20. FUJIMOTO J, Nunomura-Nakamura S, Liu Y, Lang W, et al
    Development of Kras mutant lung adenocarcinoma in mice with knockout of the airway lineage-specific gene Gprc5a.
    Int J Cancer. 2017;141:1589-1599.
    PubMed     Text format     Abstract available


  21. LIU HX, Tao LL, Zhang J, Zhu YG, et al
    Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects.
    Int J Cancer. 2017 Oct 11. doi: 10.1002/ijc.31098.
    PubMed     Text format     Abstract available


    September 2017
  22. BRYANT JL, Gieling RG, Meredith SL, Allen TJ, et al
    Novel carbonic anhydrase IX-targeted therapy enhances the anti-tumour effects of cisplatin in small cell lung cancer.
    Int J Cancer. 2017 Sep 14. doi: 10.1002/ijc.31042.
    PubMed     Text format     Abstract available


    August 2017
  23. ZHANG K, Wang J, Tong TR, Wu X, et al
    Loss of H2B monoubiquitination is associated with poor-differentiation and enhanced malignancy of lung adenocarcinoma.
    Int J Cancer. 2017;141:766-777.
    PubMed     Text format     Abstract available


  24. GUPTA SK, Guzman EAT, Meenach SA
    Co-administration of a tumor-penetrating peptide improves the therapeutic efficacy of paclitaxel in a novel air-grown lung cancer 3D spheroid model.
    Int J Cancer. 2017 Aug 2. doi: 10.1002/ijc.30913.
    PubMed     Text format     Abstract available


    July 2017
  25. LI W, Xie SH, Tse LA, Lagergren J, et al
    Digitalis Use and Lung Cancer Risk by Histological Type in Men.
    Int J Cancer. 2017 Jul 27. doi: 10.1002/ijc.30908.
    PubMed     Text format     Abstract available


  26. MORAVCIKOVA E, Krepela E, Donnenberg VS, Donnenberg AD, et al
    BOK displays cell death-independent tumor suppressor activity in non-small cell lung carcinoma.
    Int J Cancer. 2017 Jul 26. doi: 10.1002/ijc.30906.
    PubMed     Text format     Abstract available


  27. KETTUNEN E, Hernandez-Vargas H, Cros MP, Durand G, et al
    Asbestos-associated genome-wide DNA methylation changes in lung cancer.
    Int J Cancer. 2017 Jul 19. doi: 10.1002/ijc.30897.
    PubMed     Text format     Abstract available


  28. LEE WY, Chen PC, Wu WS, Wu HC, et al
    Panobinostat Sensitizes KRAS-Mutant Non-Small Cell Lung Cancer to Gefitinib by Targeting TAZ.
    Int J Cancer. 2017 Jul 14. doi: 10.1002/ijc.30888.
    PubMed     Text format     Abstract available


  29. GU F, Zhang H, Hyland PL, Berndt S, et al
    Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia.
    Int J Cancer. 2017 Jul 12. doi: 10.1002/ijc.30883.
    PubMed     Text format     Abstract available


  30. KNIPS J, Czech-Sioli M, Spohn M, Heiland M, et al
    Spontaneous lung metastasis formation of human Merkel cell carcinoma cell lines transplanted into scid mice.
    Int J Cancer. 2017;141:160-171.
    PubMed     Text format     Abstract available


    May 2017
  31. XIE K, Chen M, Zhu M, Wang C, et al
    A polymorphism in miR-1262 regulatory region confers the risk of lung cancer in Chinese population.
    Int J Cancer. 2017 May 16. doi: 10.1002/ijc.30788.
    PubMed     Text format     Abstract available


  32. NAJMEH S, Cools-Lartigue J, Rayes RF, Gowing S, et al
    Neutrophil extracellular traps sequester circulating tumor cells via beta1-integrin mediated interactions.
    Int J Cancer. 2017;140:2321-2330.
    PubMed     Text format     Abstract available


  33. MEYERS TJ, Chang SC, Chang PY, Morgenstern H, et al
    Case-control study of cumulative cigarette tar exposure and lung and upper aerodigestive tract cancers.
    Int J Cancer. 2017;140:2040-2050.
    PubMed     Text format     Abstract available


    April 2017
  34. LOBB RJ, van Amerongen R, Wiegmans A, Ham S, et al
    Exosomes derived from mesenchymal non-small cell lung cancer cells promote chemoresistance.
    Int J Cancer. 2017 Apr 26. doi: 10.1002/ijc.30752.
    PubMed     Text format     Abstract available


  35. BEN KHEDHER S, Neri M, Papadopoulos A, Christiani DC, et al
    Menstrual and reproductive factors and lung cancer risk: A pooled analysis from the International Lung Cancer consortium (ILCCO).
    Int J Cancer. 2017 Apr 25. doi: 10.1002/ijc.30750.
    PubMed     Text format     Abstract available


  36. WANG SS, Zimmermann M, Zhang H, Lin TY, et al
    A Diagnostic Microdosing Approach to Investigate Platinum Sensitivity in Non-Small Cell Lung Cancer.
    Int J Cancer. 2017 Apr 24. doi: 10.1002/ijc.30747.
    PubMed     Text format     Abstract available


  37. GROMOWSKI T, Gapska P, Scott RJ, Kaklewski K, et al
    Serum 25(OH)D concentration, common variants of the VDR gene and lung cancer occurrence.
    Int J Cancer. 2017 Apr 15. doi: 10.1002/ijc.30740.
    PubMed     Text format     Abstract available


  38. GOWING SD, Chow SC, Cools-Lartigue JJ, Chen CB, et al
    Gram-Positive Pneumonia Augments Non-Small Cell Lung Cancer Metastasis Via Host Toll-like Receptor 2 Activation.
    Int J Cancer. 2017 Apr 12. doi: 10.1002/ijc.30734.
    PubMed     Text format     Abstract available


  39. CAROZZI FM, Bisanzi S, Carrozzi L, Falaschi F, et al
    Multimodal lung cancer screening using the ITALUNG Biomarker Panel and Low Dose Computed Tomography. Results of the ITALUNG biomarker study.
    Int J Cancer. 2017 Apr 7. doi: 10.1002/ijc.30727.
    PubMed     Text format     Abstract available


  40. HELLAND A, Brustugun OT, Nakken S, Halvorsen AR, et al
    High number of kinome-mutations in non-small cell lung cancer is associated with reduced immune response and poor relapse-free survival.
    Int J Cancer. 2017 Apr 7. doi: 10.1002/ijc.30726.
    PubMed     Text format     Abstract available


  41. LIN J, Gill A, Zahm SH, Carter CA, et al
    Metformin Use and Survival after Non-Small Cell Lung Cancer: A Cohort Study in the U.S. Military Health System.
    Int J Cancer. 2017 Apr 5. doi: 10.1002/ijc.30724.
    PubMed     Text format     Abstract available


  42. FRANK C, Sundquist J, Yu H, Hemminki A, et al
    Concordant and discordant familial cancer: Familial risks, proportions and population impact.
    Int J Cancer. 2017;140:1510-1516.
    PubMed     Text format     Abstract available


  43. RAASCHOU-NIELSEN O, Pedersen M, Stafoggia M, Weinmayr G, et al
    Outdoor air pollution and risk for kidney parenchyma cancer in 14 European cohorts.
    Int J Cancer. 2017;140:1528-1537.
    PubMed     Text format     Abstract available


  44. TANG Z, Li J, Shen Q, Feng J, et al
    Contribution of upregulated dipeptidyl peptidase 9 (DPP9) in promoting tumoregenicity, metastasis and the prediction of poor prognosis in non-small cell lung cancer (NSCLC).
    Int J Cancer. 2017;140:1620-1632.
    PubMed     Text format     Abstract available


    March 2017
  45. DONG J, Cheng Y, Zhu M, Wen Y, et al
    Fine Mapping of Chromosome 5p15.33 Identifies Novel Lung Cancer Susceptibility Loci in Han Chinese.
    Int J Cancer. 2017 Mar 23. doi: 10.1002/ijc.30702.
    PubMed     Text format     Abstract available


  46. GOLDWASSER DL
    Estimation of the tumor size at cure threshold among aggressive non-small cell lung cancers (NSCLCs): evidence from the surveillance, epidemiology, and end results (SEER) program and the national lung screening trial (NLST).
    Int J Cancer. 2017;140:1280-1292.
    PubMed     Text format     Abstract available


  47. SHI H, Zhang J, Han X, Li H, et al
    Recruited monocytic myeloid-derived suppressor cells promote the arrest of tumor cells in the premetastatic niche through an IL-1beta-mediated increase in E-selectin expression.
    Int J Cancer. 2017;140:1370-1383.
    PubMed     Text format     Abstract available


  48. YANG Z, Hackshaw A, Feng Q, Fu X, et al
    Comparison of gefitinib, erlotinib and afatinib in non-small cell lung cancer: A meta-analysis.
    Int J Cancer. 2017 Mar 14. doi: 10.1002/ijc.30691.
    PubMed     Text format     Abstract available


  49. WEBER M, Yap S, Goldsbury D, Manners D, et al
    Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCOM2012 risk prediction tool.
    Int J Cancer. 2017 Mar 1. doi: 10.1002/ijc.30673.
    PubMed     Text format     Abstract available


    February 2017
  50. SHIEH JM, Tang YA, Hu FH, Huang WJ, et al
    A histone deacetylase inhibitor enhances expression of genes inhibiting Wnt pathway and augments activity of DNA demethylation reagent against non-small cell lung cancer.
    Int J Cancer. 2017 Feb 24. doi: 10.1002/ijc.30664.
    PubMed     Text format     Abstract available


  51. LIN TY, Hsu HY, Sun WH, Wu TH, et al
    Induction of Cbl-dependent epidermal growth factor receptor degradation in Ling Zhi-8 suppressed lung cancer.
    Int J Cancer. 2017 Feb 15. doi: 10.1002/ijc.30649.
    PubMed     Text format     Abstract available


    January 2017
  52. FEHRINGER G, Brenner DR, Zhang ZF, Lee YA, et al
    Alcohol and Lung Cancer Risk Among Never Smokers: A Pooled Analysis from the International Lung Cancer Consortium and the SYNERGY Study.
    Int J Cancer. 2017 Jan 24. doi: 10.1002/ijc.30618.
    PubMed     Text format     Abstract available


  53. HAN SS, Ten Haaf K, Hazelton WD, Munshi VN, et al
    The impact of overdiagnosis on the selection of efficient lung cancer screening strategies.
    Int J Cancer. 2017 Jan 10. doi: 10.1002/ijc.30602.
    PubMed     Text format     Abstract available


  54. ZHANG LL, Kan M, Zhang MM, Yu SS, et al
    Multiregion sequencing reveals the intratumor heterogeneity of driver mutations in TP53-driven non-small cell lung cancer.
    Int J Cancer. 2017;140:103-108.
    PubMed     Text format     Abstract available


  55. KAMMERER-JACQUET SF, Crouzet L, Brunot A, Dagher J, et al
    Independent association of PD-L1 expression with noninactivated VHL clear cell renal cell carcinoma-A finding with therapeutic potential.
    Int J Cancer. 2017;140:142-148.
    PubMed     Text format     Abstract available


  56. VAZQUEZ R, Licandro SA, Astorgues-Xerri L, Lettera E, et al
    Promising in vivo efficacy of the BET bromodomain inhibitor OTX015/MK-8628 in malignant pleural mesothelioma xenografts.
    Int J Cancer. 2017;140:197-207.
    PubMed     Text format     Abstract available


    December 2016
  57. ZHANG Y, Xu J, Lou Y, Hu S, et al
    Pretreatment Direct Bilirubin and Total Cholesterol Are Significant Predictors of Overall Survival in Advanced Non-small Cell Lung Cancer Patients with EGFR Mutations.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30581.
    PubMed     Text format     Abstract available


  58. MANDRIOTA SJ, Tenan M, Ferrari P, Sappino AP, et al
    Aluminium chloride promotes tumorigenesis and metastasis in normal murine mammary gland epithelial cells.
    Int J Cancer. 2016;139:2781-2790.
    PubMed     Text format     Abstract available


    November 2016
  59. POON CC, Kelly JJ
    Development of crizotinib, a rationally designed tyrosine kinase inhibitor for non-small cell lung cancer.
    Int J Cancer. 2016 Nov 22. doi: 10.1002/ijc.30533.
    PubMed     Text format     Abstract available


  60. LI L, Yang L, Wang L, Wang F, et al
    Impaired T cell function in malignant pleural effusion is caused by TGF-beta derived predominantly from macrophages.
    Int J Cancer. 2016;139:2261-9.
    PubMed     Text format     Abstract available


  61. NAGY A, Pongor LS, Szabo A, Santarpia M, et al
    KRAS driven expression signature has prognostic power superior to mutation status in non-small cell lung cancer.
    Int J Cancer. 2016 Nov 8. doi: 10.1002/ijc.30509.
    PubMed     Text format     Abstract available


  62. JIA M, Zhu M, Zhou F, Wang M, et al
    Genetic variants of JNK and p38alpha pathways and risk of non-small cell lung cancer in an Eastern Chinese population.
    Int J Cancer. 2016 Nov 5. doi: 10.1002/ijc.30508.
    PubMed     Text format     Abstract available


    October 2016
  63. PEREA F, Bernal M, Sanchez-Palencia A, Carretero J, et al
    The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration.
    Int J Cancer. 2016 Oct 27. doi: 10.1002/ijc.30489.
    PubMed     Text format     Abstract available


  64. TRABERT B, Eldridge RC, Pfeiffer RM, Shiels MS, et al
    Pre-diagnostic circulating inflammation markers and endometrial cancer risk in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial.
    Int J Cancer. 2016 Oct 22. doi: 10.1002/ijc.30478.
    PubMed     Text format     Abstract available


  65. WANG D, Pham NA, Tong J, Sakashita S, et al
    Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.
    Int J Cancer. 2016 Oct 17. doi: 10.1002/ijc.30472.
    PubMed     Text format     Abstract available


    September 2016
  66. OHYAMA K, Yoshimi H, Aibara N, Nakamura Y, et al
    Immune complexome analysis reveals the specific and frequent presence of immune complex antigens in lung cancer patients: A pilot study.
    Int J Cancer. 2016 Sep 29. doi: 10.1002/ijc.30455.
    PubMed     Text format     Abstract available


  67. BAGLIETTO L, Ponzi E, Haycock P, Hodge A, et al
    DNA methylation changes measured in pre-diagnostic peripheral blood samples are associated with smoking and lung cancer risk.
    Int J Cancer. 2016 Sep 15. doi: 10.1002/ijc.30431.
    PubMed     Text format     Abstract available


    August 2016
  68. HONG S, Mok Y, Jeon C, Jee SH, et al
    Tuberculosis, smoking and risk for lung cancer incidence and mortality.
    Int J Cancer. 2016 Aug 13. doi: 10.1002/ijc.30384.
    PubMed     Text format     Abstract available


  69. ZHANG Y, Breitling LP, Balavarca Y, Holleczek B, et al
    Comparison and combination of blood DNA methylation at smoking-associated genes and at lung cancer related genes in prediction of lung cancer mortality.
    Int J Cancer. 2016 Aug 9. doi: 10.1002/ijc.30374.
    PubMed     Text format     Abstract available


    July 2016
  70. WANG A, Qin F, Hedlin H, Desai M, et al
    Physical activity and sedentary behavior in relation to lung cancer incidence and mortality in older women: The Women's Health Initiative.
    Int J Cancer. 2016 Jul 20. doi: 10.1002/ijc.30281.
    PubMed     Text format     Abstract available


  71. TOMCZAK A, Miller AB, Weichenthal SA, To T, et al
    Long-term exposure to fine particulate matter air pollution and the risk of lung cancer among participants of the Canadian National Breast Screening Study.
    Int J Cancer. 2016 Jul 6. doi: 10.1002/ijc.30255.
    PubMed     Text format     Abstract available


  72. ZHAO QT, Yuan Z, Zhang H, Zhang XP, et al
    Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients.
    Int J Cancer. 2016;139:164-70.
    PubMed     Text format     Abstract available


  73. YANG M, Xu X, Cai J, Ning J, et al
    NSCLC harboring EGFR exon-20 insertions after the regulatory C-helix of kinase domain responds poorly to known EGFR inhibitors.
    Int J Cancer. 2016;139:171-6.
    PubMed     Text format     Abstract available


    June 2016
  74. WANG J, Su X, Yang L, Qiao F, et al
    The influence of myeloid-derived suppressor cells on angiogenesis and tumor growth after cancer surgery.
    Int J Cancer. 2016;138:2688-99.
    PubMed     Text format     Abstract available


    May 2016
  75. XIE K, Liang C, Li Q, Yan C, et al
    Role of ATG10 expression quantitative trait loci in non-small cell lung cancer survival.
    Int J Cancer. 2016 May 26. doi: 10.1002/ijc.30205.
    PubMed     Text format     Abstract available


    April 2016
  76. AIZAWA K, Liu C, Tang S, Veeramachaneni S, et al
    Tobacco carcinogen (NNK) induces both lung cancer and non-alcoholic steatohepatitis and hepatocellular carcinomas in ferrets which can be attenuated by lycopene supplementation.
    Int J Cancer. 2016 Apr 26. doi: 10.1002/ijc.30161.
    PubMed     Text format     Abstract available


    March 2016
  77. PIRIE K, Peto R, Green J, Reeves GK, et al
    Lung cancer in never-smokers.
    Int J Cancer. 2016 Mar 8. doi: 10.1002/ijc.30084.
    PubMed     Text format     Abstract available


    February 2016
  78. MEDER L, Konig K, Ozretic L, Schultheis AM, et al
    NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas.
    Int J Cancer. 2016;138:927-38.
    PubMed     Text format     Abstract available


    January 2016
  79. JANG YS, Kang JH, Woo JK, Kim HM, et al
    Ninjurin1 suppresses metastatic property of lung cancer cells through inhibition of Interleukin-6 signaling pathway.
    Int J Cancer. 2016 Jan 27. doi: 10.1002/ijc.30021.
    PubMed     Text format     Abstract available


  80. WANG Y, Liu H, Ready NE, Su L, et al
    Genetic variants in ABCG1 are associated with survival of non-small cell lung cancer patients.
    Int J Cancer. 2016 Jan 12. doi: 10.1002/ijc.29991.
    PubMed     Text format     Abstract available


  81. MAHALE J, Smagurauskaite G, Brown K, Thomas A, et al
    The role of stromal fibroblasts in lung carcinogenesis: A target for chemoprevention?
    Int J Cancer. 2016;138:30-44.
    PubMed     Text format     Abstract available


    December 2015
  82. ZHANG X, Ai F, Li X, She X, et al
    Inflammation-induced S100A8 activates Id3 and promotes colorectal tumorigenesis.
    Int J Cancer. 2015;137:2803-14.
    PubMed     Text format     Abstract available


  83. YAMADA K, Maishi N, Akiyama K, Towfik Alam M, et al
    CXCL12-CXCR7 axis is important for tumor endothelial cell angiogenic property.
    Int J Cancer. 2015;137:2825-36.
    PubMed     Text format     Abstract available


  84. DAL BELLO MG, Alama A, Barletta G, Coco S, et al
    Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors.
    Int J Cancer. 2015;137:2947-58.
    PubMed     Text format     Abstract available


  85. YUAN JM, Nelson HH, Butler LM, Carmella SG, et al
    Genetic determinants of cytochrome P450 2A6 activity and biomarkers of tobacco smoke exposure in relation to risk of lung cancer development in the Shanghai Cohort Study.
    Int J Cancer. 2015 Dec 13. doi: 10.1002/ijc.29963.
    PubMed     Text format     Abstract available


  86. KJAERGAARD AD, Nordestgaard BG, Johansen JS, Bojesen SE, et al
    Observational and genetic plasma YKL-40 and cancer in 96,099 individuals from the general population.
    Int J Cancer. 2015;137:2696-704.
    PubMed     Text format     Abstract available


    May 2015
  87. BAI R, Weng C, Dong H, Li S, et al
    MicroRNA-409-3p suppresses colorectal cancer invasion and metastasis partly by targeting GAB1 expression.
    Int J Cancer. 2015 May 20. doi: 10.1002/ijc.29607.
    PubMed     Text format     Abstract available


  88. HLEYHEL M, Belot A, Bouvier AM, Tattevin P, et al
    Trends in survival after cancer diagnosis among HIV-Infected Individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 Cohort.
    Int J Cancer. 2015 May 14. doi: 10.1002/ijc.29603.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: